维普期刊资源整合服务平台（V6.5）

68篇 您的检索式：作者名="LINARDOU H"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Assessment of somatic K-ras mutations as a mechanism associated with resist- ance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic eolorectal cancer显示文摘	Linardou H Dahabreh IJ Kanaloupiti D	2008	Lancet Oncol2008，9，10：	1
2	Trastuzumab in the adjuvant treatment of earlvstage breast cancels, a svstematic review recta - analysis of randomized controlled trials 显示文摘	Dahabreh IJ Linardou H Siannis F	2008	Oneologist2008，13，：	1
3	Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC 显示文摘	Linardou H Dahabreh U Bafaloukos D	2009	Nat Rev Clin Oncol2009，6，6：	1
4	Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC 显示文摘	Linardou H Dahabreh IJ Bafaloukos D	2009	NatRev Clin Oncol2009，6，6：	1
5	EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment:a systematic review and meta analysis in non-small-cell lung cancer显示文摘	Dahabreh I J Linardou H Kosmidis P	2011	Ann Oncol2011，22，3：	1
6	Assessment of somatic K-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer显示文摘	Linardou H Dahabreh IJ Kanaloupiti D	2008	Lancet Oncol2008，9，10：	1
7	Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circum- vention strategies 显示文摘	Murray S Briasoulis E Linardou H	2012	Cancer Treatment Reviews2012，38，7：	1
8	Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC 显示文摘	Linardou H Dahabreh I J Bafaloukos D et at	2009	Nat Rev Clin Oncol2009，6，6：	1
9	Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents:a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer显示文摘	Linardou H Dahabreh IJ Kanaloupiti D		0，，10：	1
10	EGFR gent copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment:a systematic review and meta - analysis in non - small - cell lung cancer显示文摘	Dahabrch I J Linardou H Kosmidis P ct al	2011	Ann Oncol2011，22，3：	1
11	Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial 显示文摘	Eggermont AM Schraffordt Koops H Linard D	1996	J Clin Oncol1996，14，10：	1
12	Assessment of somat- ic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer显示文摘	Linardou H Dahabreh IJ Kanaloupiti D	2008	Lancet Oncol2008，9，10：	1
13	Mechanisms of resistance to epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small-cell lung cancer: clinical and molecular considerations显示文摘	Pallis A Briasoulis E Linardou H	2011	Current Medicinal Chemistry2011，18，11：	1
14	Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors innon-small cell lung cancer 显示文摘	Dahabreh IJ Linardou H Siannis F	2010	Clin Cancer Res2010，16，1：	1
15	Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non-small cell lung cancer 显示文摘	Dahabreh IJ Linardou H Siannis F	2010	Clin Cancer Res2010，16，1：	1
16	Trastuzumab in the adjuvant treatment of early-stage breast cancer,a systematic review and recta-a- nalysis of randomized trials显示文摘	Dahabreh IJ Linardou H Siannis F	2008	Oncologist2008，13，6：	1
17	Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcima:a phase Ⅱ study of the Hellenic Cooperative Oncology Group 显示文摘	Bafaloukos D Papadimitriou C Linardou H	2004	Br J Cancer2004，91，9：	1
18	Assessment of somatic KRAS mutations as a mechanism associated with resistance to EGFR-targeted agents:a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer显示文摘	Linardou H Dahabreh IJ Kanaloupiti D	2008	Lancet Oncol2008，9，10：	1
19	As- sessment of somatic k-ras mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in ad- vanced non-small-cell lung cancer and metastatic colo- rectal cancer显示文摘	Linardou H Dahabreh I J Kanaloupiti D	2005	Lancet Oncol2005，9，10：	1
20	Assessment of somatic K-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents:a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer 显示文摘	Linardou H Dahabreh U Kanaloupiti D	2008	Lancet Onco12008，9，10：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示